DIABETES 润色咨询

DIABETES

出版年份：1952 年文章数：7177 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：3.3% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2015-04-30 vvjj

    审稿速度:3.0
    经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2014-12-11 CellRep

    好杂志啊。。。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2014-10-29 匿名用户

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2014-09-28 匿名用户

    投稿命中率:25.0
    经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2014-09-26 匿名用户

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2014-05-20 匿名用户

    5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？

    这种算是没有被秒拒么?

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2014-03-19 mice

    审稿速度:2.0 | 投稿命中率:50.0
    经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2014-03-02 cweimed

    糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2013-02-04 magicb

    审稿速度:1.0 | 投稿命中率:50.0
    经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=511566, encodeId=a257511566b6, content=审稿速度:3.0<br>经验分享：3月2日投稿，4月24拒稿。审稿非常认真，意见很中肯，对照修改后准备投另一家杂志, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=578, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=8be0100274, createdName=vvjj, createdTime=Thu Apr 30 19:21:00 CST 2015, time=2015-04-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=508354, encodeId=36cc508354ef, content=好杂志啊。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=488, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=63471608243, createdName=CellRep, createdTime=Thu Dec 11 11:41:00 CST 2014, time=2014-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=507144, encodeId=e1b450e1448e, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：做的比较详细自认为，但是碰到眼科专家，把一些现象和方法否定了。一审1个月后被拒。不好发，不能碰运气, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=520, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Wed Oct 29 00:41:00 CST 2014, time=2014-10-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506397, encodeId=8df050639efb, content=投稿命中率:25.0<br>经验分享：我10年投了一个,当时中的比较容易.但是自从前年换了Editor之后,就不喜欢纯基础研究了,要和临床相联系,今年年初投了一个,墨迹了大半年,刚被接收,补了好多试验., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=560, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Sun Sep 28 10:48:00 CST 2014, time=2014-09-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=506345, encodeId=d229506345d1, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：投过一篇，送审3周后返回评审意见，有新意，但是机制没有阐明清楚，被拒, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=495, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Sep 26 10:41:00 CST 2014, time=2014-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=503025, encodeId=31ff50302525, content=5月6号投了一篇，到现在已经2个星期了，状态一直显示with associated editor，也没有显示送出外审，神马情况？ <br> <br> 这种算是没有被秒拒么?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=501, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Tue May 20 00:10:00 CST 2014, time=2014-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501858, encodeId=8e08501858aa, content=审稿速度:2.0 | 投稿命中率:50.0<br>经验分享：糖尿病领域的权威顶尖杂志，好好阅读文献，一定会有好的idea, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=594, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/13/5da7894b7d7fb0b5636229a684dadb55.jpg, createdBy=2f7195813, createdName=mice, createdTime=Wed Mar 19 16:55:00 CST 2014, time=2014-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=501515, encodeId=390450151557, content=糖尿病方向权威杂志，很难，不接收非约稿的review及meta analysis，去年投过1篇，2天直接被拒。看来需要努力啊！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a61154144, createdName=cweimed, createdTime=Sun Mar 02 16:23:00 CST 2014, time=2014-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=493791, encodeId=5622493e91de, content=审稿速度:1.0 | 投稿命中率:50.0<br>经验分享：今年目前投2个，因为我老板经常给此杂志做reviewer，所以知道审稿限定3周。第一篇投后拒，按照提的意见做实验修改后2个月复投，10天后直接接受。第二篇现在已经送2周review，估计快有反馈了。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=634, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e08177277, createdName=magicb, createdTime=Mon Feb 04 16:06:00 CST 2013, time=2013-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=487058, encodeId=73cd48e058e9, content=审稿速度:1.0 | 投稿命中率:25.0<br>经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=431, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=473857163, createdName=wlmqren101, createdTime=Sat Mar 03 15:52:00 CST 2012, time=2012-03-03, status=1, ipAttribution=)]
    2012-03-03 wlmqren101

    审稿速度:1.0 | 投稿命中率:25.0
    经验分享：糖尿病顶级杂志，审稿很快3周之内，reviewer很严格，提出了很多具体且对文章有益的建议，根据意见修改后，改投别的杂志了！

    0

共65条页码: 4/7页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分